hrp0095p1-108 | Growth and Syndromes | ESPE2022
Efficacy, Observer-Reported Outcomes, and Safety of Once-Weekly Somapacitan in Children with Growth Hormone Deficiency (GHD): 4-Year Results from the REAL 3 Trial
Sävendahl Lars , Battelino Tadej , Højby Rasmussen Michael , Brod Meryl , Wai Lee Kai , Saenger Paul , Horikawa Reiko
hrp0092rfc12.6 | Growth and Syndromes (to include Turner syndrome) | ESPE2019
Albertsson Wikland Kerstin , Niklasson Aimon , Holmgren Anton , Gelander Lars , Nierop Andreas
hrp0089fc10.2 | Late Breaking | ESPE2018
Savendal Lars , Rasmussen Michael , Horikawa Reiko , Khadilkar Vaman , Battelino Tadej , Saenger Paul
hrp0089p1-p169 | Growth & Syndromes P1 | ESPE2018
Albertsson-Wikland Kerstin , Niklasson Aimon , Gelander Lars , Holmgren Anton , Aronson Stefan , Sjoberg Agneta , Lissner Lauren
hrp0089p1-p170 | Growth & Syndromes P1 | ESPE2018
Gelander Lars , Niklasson Aimon , Holmgren Anton , Saari Antti , Dunkel Leo , Albertsson-Wikland Kerstin
hrp0089p2-p252 | Growth & Syndromes P2 | ESPE2018
Polak Michel , Blair Jo , Rohrer Tilman R. , Pietropoli Alberto , Tonnes Pedersen Birgitte , Savendahl Lars
hrp0086p2-p643 | Growth P2 | ESPE2016
Savendahl Lars , Rohrer Tilman R , Pournara Effie , Pedersen Birgitte Tonnes , Blankenstein Oliver
hrp0086p2-p671 | Growth P2 | ESPE2016
Brod Meryl , Wilkinson Lars , Alolga Suzanne Lessard , Hojbjerre Lise , Beck Jane , Rasmussen Michael Hojby
hrp0082fc3.3 | Diabetes | ESPE2014
Ekstrom Klas , Skogsberg Lars , Fors Hans , Carlsson-Skwirut Christine , Bang Peter
hrp0082p1-d3-51 | Bone (1) | ESPE2014
Shanbhogue Vikram v. , Hansen Stinus , Folkestad Lars , Brixen Kim , Beck-Nielsen Signe Sparre